Fluidigm Corporation logo
Fluidigm Corporation FLDM

Fluidigm Corporation Financial Ratios 2011-2025 | FLDM

Annual Financial Ratios Fluidigm Corporation

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-9.1 -4.1 -5.8 -3.6 -2.3 -3.6 -20.3 -68.7 -19.0 -11.8

P/S

3.5 2.2 3.0 2.1 1.7 1.7 9.2 16.0 6.9 6.2

EV/EBITDA

-13.6 -8.2 -13.2 -8.9 -6.1 -9.4 -45.1 -74.2 -19.0 -18.0

PEG

-0.38 -0.12 -0.3 -0.12 0.06 -1.72 0.1 -2.46 -0.36 -0.15

P/B

3.5 1.7 4.7 7.0 3.3 1.7 7.1 11.8 3.6 4.6

P/CF

-17.1 -7.0 -13.3 -8.4 -4.0 -4.2 -35.6 -181.0 -18.2 -13.8

ROE %

-38.13 -42.18 -81.83 -195.68 -142.74 -46.40 -35.12 -17.14 -18.90 -39.49

ROA %

-16.33 -24.47 -19.43 -21.07 -24.80 -14.37 -12.96 -14.14 -16.73 -28.33

ROCE %

-18.87 -22.35 -18.10 -22.99 -26.43 -15.88 -10.88 -17.57 -17.69 -26.31

DSO

67.2 59.1 53.8 53.9 51.1 81.0 70.2 54.1 90.0 78.8

DIO

131.1 95.7 92.5 110.2 159.6 140.3 136.2 147.2 170.7 165.2

DPO

61.4 44.9 28.6 30.8 31.5 47.7 50.4 78.6 60.9 111.0

All numbers in USD currency

Multiples are an important financial analysis tool for the company Fluidigm Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Diagnostics research industry

Issuer Price % 24h Market Cap Country
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 17.13 1.66 % $ 99.4 M israelIsrael
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 12.15 2.14 % $ 345 M israelIsrael
DexCom DexCom
DXCM
$ 66.06 -1.34 % $ 25.5 B usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Exact Sciences Corporation Exact Sciences Corporation
EXAS
$ 101.57 0.07 % $ 18.8 B usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 16.0 1.59 % $ 172 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.56 -3.7 % $ 1.98 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Castle Biosciences Castle Biosciences
CSTL
$ 38.95 0.82 % $ 1.08 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 227.29 0.42 % $ 166 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 26.94 -0.74 % $ 815 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 408.65 1.08 % $ 29.9 B schweizSchweiz
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
NeoGenomics NeoGenomics
NEO
$ 12.15 2.53 % $ 1.54 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
$ 6.84 -0.36 % $ 1.48 B usaUSA
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
- - $ 10.7 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 19.9 -3.21 % $ 1.07 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 2.12 - $ 538 M usaUSA
Celcuity Celcuity
CELC
$ 101.74 -3.33 % $ 4.01 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
$ 3.35 -6.42 % $ 107 K usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 26.46 -0.62 % $ 20 B niderlandNiderland
Co-Diagnostics Co-Diagnostics
CODX
$ 0.3 -13.39 % $ 8.8 M usaUSA
Precipio Precipio
PRPO
$ 24.67 -1.2 % $ 32 M usaUSA
Quidel Corporation Quidel Corporation
QDEL
$ 28.82 0.07 % $ 1.21 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 224.13 0.84 % $ 40.6 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
$ 45.14 -0.21 % $ 10 B niderlandNiderland
Guardant Health Guardant Health
GH
$ 103.55 1.45 % $ 12.7 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Sotera Health Company Sotera Health Company
SHC
$ 16.76 -0.42 % $ 4.74 B usaUSA
Soleno Therapeutics Soleno Therapeutics
SLNO
$ 49.79 -4.25 % $ 2 B usaUSA
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
$ 574.27 0.46 % $ 219 B usaUSA
Illumina Illumina
ILMN
$ 134.66 -0.16 % $ 21.4 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 197.59 2.36 % $ 10.2 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
$ 0.96 -10.6 % $ 61.9 M irlandaIrlanda
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
$ 31.39 1.47 % $ 1.88 B usaUSA
Quotient Limited Quotient Limited
QTNT
- -11.32 % $ 1.1 M schweizSchweiz
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 184.04 0.81 % $ 20.4 B usaUSA
Biodesix Biodesix
BDSX
$ 7.63 -2.8 % $ 989 M usaUSA
Myriad Genetics Myriad Genetics
MYGN
$ 7.07 -2.01 % $ 641 M usaUSA